Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes - Wikidata - wikimedia - TriplyDB

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

http://www.wikidata.org/entity/Q24612992

about

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.Retroviral vectors for analysis of viral mutagenesis and recombination.Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo.Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation.APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.Retroelements versus APOBEC3 family members: No great escape from the magnificent seven Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein Host restriction factors in retroviral infection: promises in virus-host interaction.DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition.Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.Association of single nucleotide polymorphisms of APOBEC3G with susceptibility to HIV-1 infection and disease progression among men engaging in homosexual activity in northern China.MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.Patterns of genomic site inheritance in HIV-1M inter-subtype recombinants delineate the most likely genomic sites of subtype-specific adaptation.

P2860

Q21245213-E6012457-5827-4F2D-A33D-87B57DFD4F1A Q26823568-B0E10A0C-BA17-4E3E-AA3B-AF7A58911C75 Q26851152-F124A8D8-A2F6-4D87-8E76-325B86801DBA Q30276860-55B0CCA5-6E94-4DFA-8701-79431E0271B1 Q34303615-84E95741-583D-4AF5-A4DC-EA6006DC9551 Q35022585-E08183F5-3D9D-404E-94CE-FC8C09B7A476 Q35489088-ABE9B03B-052D-4BC9-A540-AA4D10D47E47 Q35666084-1A3A704D-BCCD-46C9-B302-22DA3AFC99DB Q35834559-F4B893AA-2C71-4672-8F5E-7DFBDBE1A24F Q35888106-BB11555B-60A9-4C4F-AF8A-D76B7B4F978F Q36019696-A75BDEA4-8D0A-48E4-9552-D48A09A88534 Q36162443-F3DB814C-C035-4FE2-B8D2-2EE248F5513C Q36371387-A976E5ED-F25C-47B3-A457-DE5E213F8755 Q36432758-10621692-26B8-4930-851A-840A5E83A301 Q36548179-273047D2-24B1-435F-B473-1EE590A09ECB Q36707275-B5224FC1-C92F-4AC7-91AF-709E1754B9F2 Q36811895-32F4D755-81B1-4D64-9CE5-DA9434604D5E Q36978615-807894D8-B9CC-4A12-8225-3F05359D5658 Q37047737-57E70F1F-70E3-438A-8C85-D008BD5EC12F Q37141248-A706C88A-0002-47D8-BACD-18F61BE8B4DB Q37404667-5F6BA294-6EA8-4F10-B698-12C068CABECB Q38706845-575077E5-AFDB-463C-8963-3C7D0AA65242 Q38730130-C1111C63-6567-4FE8-9BFB-EDF383B9B17E Q38951329-5A85993A-FBF3-4769-96A0-959975E94A1B Q40509727-9755D2DA-72C5-4141-A38C-02B7CD9C7FA5 Q40927400-46BA885D-973F-4160-A999-EB0B494C7C84 Q55363352-4308C78D-7A7F-47F9-8DDD-B94817E35734

P2860

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

http://www.wikidata.org/entity/Q24612992

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@ast

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@en

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@nl

type

label

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@ast

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@en

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@nl

prefLabel

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@ast

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@en

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@nl

P1433

Q24612992-3E106899-3054-4C93-A96C-53115FC8C0BB

P1476

Q24612992-A17020F3-031E-4B9E-9D00-972625EA7B9E

P2093

Q24612992-169CC81F-C2A9-4CFC-8275-CEB928340B0F

Q24612992-1B6A7CF4-DE13-4F04-95A6-53F1B9AF258A

Q24612992-2608A7C8-24FF-41F5-9C46-D9AD759E80FE

Q24612992-ABFE6061-26D9-4DC6-8C01-A28E14CA8F62

Q24612992-BC08C296-E418-410C-95F9-0B1959465B54

Q24612992-BF42B508-9F52-433A-92F6-3605DE3FE750

Q24612992-C2E9BBD1-DCB3-4AEC-91FB-7F59F8714EED

Q24612992-D4FE060F-5A1A-4FAA-8759-8D238BC18841

Q24612992-DB0DC1F8-BA62-42CC-965E-72B7EA661A12

P2860

Q24612992-00D1C689-302F-4FBF-A762-5A91A9AAFB25

Q24612992-04297F63-F078-4BD3-BED1-3C471662C8FF

Q24612992-09B72D02-053B-4F7E-95D9-8D527D5271D5

Q24612992-0A337704-9A21-4163-893F-8B572285CBEC

Q24612992-0DA1A6ED-87E3-455C-9CBB-49E1C92C90E7

Q24612992-15A663FE-9396-4C91-8499-BA6130D264E1

Q24612992-18DF4B56-2287-4A30-AA7E-BFC6065BDDBB

Q24612992-1937B42C-A940-4582-AE55-6D6018A72EEB

Q24612992-23CC73F7-B628-47EF-B29D-E14DC27C5CCF

Q24612992-2CA9B21D-170A-455B-B45D-26911FEB07FB

P304

Q24612992-B2110E1D-2D6A-4CB8-93DB-1D37B4413DAB

P31

Q24612992-B8D2F5F3-01E1-448C-8A0B-FED8A0687D6A

P356

Q24612992-CBA96B69-C3A5-44C3-93CF-0F2AF6F3942D

P407

Q24612992-13A27E5B-87CC-4601-B66F-B149B394FE12

P433

Q24612992-817F2A5C-D825-4737-A718-1069BF9F7781

P478

Q24612992-C6EA6DB3-4715-472B-84C0-DDA84166967E

P50

Q24612992-40CAE406-AEA7-4B59-A8BB-93D179E1475A

Q24612992-60B64D98-AC04-43F1-83D9-CFE11C208207

P577

Q24612992-40FA8AB0-7077-4D49-B8AA-4274EC93D404

P698

Q24612992-EF9C0735-571A-46E7-9F9A-82F3F027A502

P921

Q24612992-D25ED1B5-6218-497B-88F7-2F6F66BDA8DF

P932

Q24612992-3702AEB5-BF77-4D84-8FCF-661F27B4AD2A

P356

JBC.M110.173286

P1433

Journal of Biological Chemistry

P1476

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

@en

P2093

David Nolan

http://www.w3.org/2001/XMLSchema#string

Hideaki Fujita

http://www.w3.org/2001/XMLSchema#string

Mari Shimura

http://www.w3.org/2001/XMLSchema#string

Masanobu Kinomoto

http://www.w3.org/2001/XMLSchema#string

Masashi Tatsumi

http://www.w3.org/2001/XMLSchema#string

Simon Mallal

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Tanaka

http://www.w3.org/2001/XMLSchema#string

Yukie Iwabu

http://www.w3.org/2001/XMLSchema#string

Yukihito Ishizaka

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Restriction of foamy viruses by APOBEC cytidine deaminases

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes

Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

P304

35350-35358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.173286

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20833716

http://www.w3.org/2001/XMLSchema#string

P921

P932

2975159

http://www.w3.org/2001/XMLSchema#string